KS
Therapeutic Areas
Krystal Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VYJUVEK | Dystrophic Epidermolysis Bullosa | Commercial |
Leadership Team at Krystal Biotech
SK
Suma Krishnan
President, Research and Development
KR
Kathryn Romano
EVP & Chief Accounting Officer
JT
John Thomas
EVP, General Counsel & Corporate Secretary
LG
Laurent Goux
EVP, General Manager Europe
JG
Julian Gangolli
Board Member
DA
Dino A. Rossi
Board Member